Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.

已完结 20 由 hezhi 发布于 2026/11/9 10:07:46

DOI:10.1016/S1470-2045(17)30111-0
作者：Peter C Thuss-Patience, Manish A Shah, Atsushi Ohtsu, Eric Van Cutsem, Jaffer A Ajani, Hugo Castro, Wasat Mansoor, Hyun Cheol Chung, Gyorgy Bodoky, Kohei S
文献类型：期刊论文
补充材料：仅需补充材料
文献链接：https://doi.org/10.1016/S1470-2045(17)30111-0

Elsevier

Abstract：Background: Although trastuzumab plus chemotherapy is the standard of care for first-line treatment of HER2-positive advanced gastric cancer, there is no established therapy in the second-li

应助信息

1小时前

yong50

21a0668edbe311f18ca2208810ba6e4f.pdf 已采纳

2小时前

Book学术机器人

2026/11/9 10:07:46 未找到该文献，机器人已退出，请等待人工下载

2026/11/9 10:07:46 Book学术AI机器人收到请求，开始寻找文献

2026/11/9 10:07:46 已向机器人发送请求

2小时前

hezhi 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierDietary patterns and adverse pregnancy outcomes: Complementary insights from a priori and a posteriori approaches in a prospective cohort